PharmaLogic Holdings Corp. manufactures and distributes radioactive isotopes in patient specific doses for various diagnostic and therapeutic procedures. The company compounds and dispenses patient specific intravenous drugs and solutions for use in diagnostic imaging, radiopharmaceutical therapies, and pharmacy services. It offers drugs in syringe, capsule, and solution forms. The company was founded in 1993 and is based in Boca Raton, Florida. It has locations in Albany and Syracuse, New York; Sayre, Pennsylvania; Bridgeport and Huntington, West Virginia; Williston, Vermont; Augusta, Maine; Traverse City, Michigan; Casper, Wyoming; and Missoula, Montana. As of August 31, 2005, PharmaLogic Holdings Corp. is a former subsidiary of RadioPharmacy Investors, LLC.